Molecular and genetic testing are increasingly used for the verification of cancer. These tests can identify specific genetic mutations or markers that are associated with certain types of cancer. For example, BRCA1 and BRCA2 gene mutations are linked to a higher risk of breast and ovarian cancers. Identifying these markers can guide targeted therapies and personalized treatment plans.
